1167818

Shire Human Genetic Therapies, Inc. — FEI 3009340644

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, MA (United States)